190 related articles for article (PubMed ID: 28580758)
1. Nuclei-specific deposits of iron and calcium in the rat thalamus after status epilepticus revealed with quantitative susceptibility mapping (QSM).
Aggarwal M; Li X; Gröhn O; Sierra A
J Magn Reson Imaging; 2018 Feb; 47(2):554-564. PubMed ID: 28580758
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation.
Dimov AV; Gillen KM; Nguyen TD; Kang J; Sharma R; Pitt D; Gauthier SA; Wang Y
Tomography; 2022 Jun; 8(3):1544-1551. PubMed ID: 35736875
[TBL] [Abstract][Full Text] [Related]
3. Quantitative MRI susceptibility mapping reveals cortical signatures of changes in iron, calcium and zinc in malformations of cortical development in children with drug-resistant epilepsy.
Lorio S; Sedlacik J; So PW; Parkes HG; Gunny R; Löbel U; Li YF; Ogunbiyi O; Mistry T; Dixon E; Adler S; Cross JH; Baldeweg T; Jacques TS; Shmueli K; Carmichael DW
Neuroimage; 2021 Sep; 238():118102. PubMed ID: 34058334
[TBL] [Abstract][Full Text] [Related]
4. APART-QSM: An improved sub-voxel quantitative susceptibility mapping for susceptibility source separation using an iterative data fitting method.
Li Z; Feng R; Liu Q; Feng J; Lao G; Zhang M; Li J; Zhang Y; Wei H
Neuroimage; 2023 Jul; 274():120148. PubMed ID: 37127191
[TBL] [Abstract][Full Text] [Related]
5. Visualization of thalamic calcium influx with quantitative susceptibility mapping as a potential imaging biomarker for repeated mild traumatic brain injury.
Schweser F; Kyyriäinen J; Preda M; Pitkänen A; Toffolo K; Poulsen A; Donahue K; Levy B; Poulsen D
Neuroimage; 2019 Oct; 200():250-258. PubMed ID: 31201986
[TBL] [Abstract][Full Text] [Related]
6. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.
Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y
J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449
[TBL] [Abstract][Full Text] [Related]
7. Magnetic susceptibility contrast variations in multiple sclerosis lesions.
Li X; Harrison DM; Liu H; Jones CK; Oh J; Calabresi PA; van Zijl PC
J Magn Reson Imaging; 2016 Feb; 43(2):463-73. PubMed ID: 26073973
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
9. MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID-based biomagnetic liver susceptometry.
Sharma SD; Fischer R; Schoennagel BP; Nielsen P; Kooijman H; Yamamura J; Adam G; Bannas P; Hernando D; Reeder SB
Magn Reson Med; 2017 Jul; 78(1):264-270. PubMed ID: 27509836
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
[TBL] [Abstract][Full Text] [Related]
11. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping].
Guan JJ; Feng YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):305-311. PubMed ID: 29643036
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
Tan H; Liu T; Wu Y; Thacker J; Shenkar R; Mikati AG; Shi C; Dykstra C; Wang Y; Prasad PV; Edelman RR; Awad IA
Invest Radiol; 2014 Jul; 49(7):498-504. PubMed ID: 24619210
[TBL] [Abstract][Full Text] [Related]
14. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
[TBL] [Abstract][Full Text] [Related]
15. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
[TBL] [Abstract][Full Text] [Related]
16. Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter.
Sun H; Walsh AJ; Lebel RM; Blevins G; Catz I; Lu JQ; Johnson ES; Emery DJ; Warren KG; Wilman AH
Neuroimage; 2015 Jan; 105():486-92. PubMed ID: 25462797
[TBL] [Abstract][Full Text] [Related]
17. Rapid automated liver quantitative susceptibility mapping.
Jafari R; Sheth S; Spincemaille P; Nguyen TD; Prince MR; Wen Y; Guo Y; Deh K; Liu Z; Margolis D; Brittenham GM; Kierans AS; Wang Y
J Magn Reson Imaging; 2019 Sep; 50(3):725-732. PubMed ID: 30637892
[TBL] [Abstract][Full Text] [Related]
18. MR Susceptibility Separation for Quantifying Lesion Paramagnetic and Diamagnetic Evolution in Relapsing-Remitting Multiple Sclerosis.
Zhu Z; Naji N; Esfahani JH; Snyder J; Seres P; Emery DJ; Noga M; Blevins G; Smyth P; Wilman AH
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38308397
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
20. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.
Schweser F; Raffaini Duarte Martins AL; Hagemeier J; Lin F; Hanspach J; Weinstock-Guttman B; Hametner S; Bergsland N; Dwyer MG; Zivadinov R
Neuroimage; 2018 Feb; 167():438-452. PubMed ID: 29097315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
